120 likes | 300 Views
Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects.
E N D
Biomarkers Market (Diagnostic Applications in Risk Assessment, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Opportunities and Forecast, 2013 - 2020 Published Date:- Dec-2013
Description Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. The global market for diagnostic biomarker is expected to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020. Pharmaceutical companies, which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, and educational institutes. The companies are also increasing their investments in research and development. ©Big Market Research
Overview Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020. However, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020. ©Big Market Research
Key Benefits • Assessment and ranking the factors that favor the market growth and those factors which act as a hindrance for the growth of the market • The market sizing and estimation period is from 2013 to 2020. Two historic years include 2011 and 2012 • The report identifies and analyses top investment pockets and top winning strategies for diagnostic biomarker market • The report analyses the various strategies adopted by some of the key companies in the market • The report tracks and analyses key innovations and patents for biomarkers in the last five years ©Big Market Research
Key Audiences • Pharmaceutical companies • Government & Private research institutes • Academic institutes • Medical device manufacturing companies ©Big Market Research
Biomarkers in Top Technologies ©Big Market Research
Top Factors Impacting DBM Market • Non-Invasive Technique • Drug Discovery and Development • Cost Effective Tool for Diagnosis • Multi-Marker Application • Accuracy and Reliability • Ethical Issues • Gene Level Diagnosis • Complex Processes • Government Regulations ©Big Market Research
Market Dynamics Drivers • Cost Effective • Non-Invasive • Accuracy in Result • Assistant in Clinical Trials • Multi-Marker Application • Gene Level Diagnosis ©Big Market Research
Market Dynamics Drivers • Cost Effective • Non-Invasive • Accuracy in Result • Assistant in Clinical Trials • Multi-Marker Application • Gene Level Diagnosis ©Big Market Research
Diagnostic Biomarker Market By Services • Assay Development • Complexity in Technique • Tissue Specific • Biomarker Validation and Testing • Clinical Errors • Time Consuming ©Big Market Research
Company Profiles • Abbott Laboratories, Inc. • Agilent Technologies Inc. • AushonBiosystem • Bio-Rad Laboratories • Eisai Co. Ltd. • Epistem Ltd. • Ge Healthcare • Roche Diagnostics Limited • Siemens AG ©Big Market Research
Get Full Information At: http://www.bigmarketresearch.com/biomarkers-market